The rapid accumulation of plastic waste is currently posing significant risks for both human health and the environment on Earth. A possible solution to this problem would be to recycle plastic waste, ...

Chris Impey has received funding from NASA, NSF, Howard Hughes Medical Institute, and the Templeton Foundation. If you look across space with a telescope, you’ll see countless galaxies, most of which ...

Google launched its new video model Veo 3.1 with improved audio output, granular editing controls, and better output for image to video. It said that Veo 3.1 builds on May’s Veo 3 release and ...

A new system, made by splitting a laser beam into 12,000 tweezers and trapping 6,100 neutral atom qubits, hit new heights for coherence times. When you purchase through links on our site, we may earn ...

This is read by an automated voice. Please report any issues or inconsistencies here. Paramount acquired the Free Press for $150 million and named its co-founder Bari Weiss as CBS News’ first-ever ...

Paramount announced Monday that it is acquiring The Free Press — a provocative news site known for criticizing mainstream media and left-leaning "woke" culture — and installing the publication's ...

LOS ANGELES, Oct 6 (Reuters) - Paramount Skydance (PSKY.O), opens new tab CEO David Ellison has named Bari Weiss editor-in-chief of CBS News, the news division of U.S. broadcaster CBS, as part of a ...

CBS News is planning to take another step to appeal to right-of-center viewers by installing Bari Weiss as editor in chief. CBS' new corporate owner, Skydance Media, is also acquiring The Free Press, ...

The newly formed media corporation Paramount Skydance has acquired The Free Press, an online news and commentary outlet co-founded by Bari Weiss, who will join CBS News as editor-in-chief. Weiss ...

U.K. Prime Minister Keir Starmer said the proposed nuclear power pact would put the U.S. and U.K. “at the forefront of global innovation.” As part of the agreement, known as the Atlantic Partnership ...

Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...